Sage Journals: Discover world-class research

Free access

Research article

First published 2005-8

Generalized Cellular Hypertrophy is Induced by a Dual-Acting PPAR Agonist in Rat Urinary Bladder Urothelium In Vivo

Martin B. Oleksiewicz, Inger Thorup, Henriette S. Nielsen [...]

Toxicologic Pathology

Retricted access

Research article

First published 2017-8

Dual Triggering With Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate

Alberta Maria Fabris, M. Cruz, V. Legidos [...]

Reproductive Sciences

Free access

Research article

First published 2014-11

The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db / db mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects

Rémy Hanf, Lesley J Millatt, Bertrand Cariou [...]

Diabetes & Vascular Disease Research

Free access

Research article

First published 2020-04-03

The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson’s Disease

Lingyu Zhang, Liping Zhang, Yanwei Li [...]

Journal of Parkinson’s Disease

Open access

Research article

First published 2020

Long-term outcomes of monascin – a novel dual peroxisome proliferator-activated receptor γ/nuclear factor-erythroid 2 related factor-2 agonist in experimental intracerebral hemorrhage

Pengcheng Fu, Jiachen Liu, Qinqin Bai [...]

Therapeutic Advances in Neurological Disorders

Free access

Research article

First published 2012-6

Efficient Syntheses of Dual Radioisotope-Labelled PF-00217830,a D 2 -Partial Agonist for the Treatment of Schizophrenia Disorder

Yinsheng Zhang, Keith T. Garnes, Donna Brown

Journal of Chemical Research

Open access

Research article

First published 2026-4

The Role of EP3 Agonism in Intraocular Pressure-Lowering by Sepetaprost,a Novel Dual Agonist of FP and EP3 Receptors,in Monkeys

Kentaro Maki, Erika Kimura, Yasuko Yamamoto [...]

Journal of Ocular Pharmacology and Therapeutics

Free access

Research article

First published 2007-09

Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPARα/γ agonist,tesaglitazar

Bjorn Fagerberg, Herbert Schuster, Grethe Støa Birketvedt [...]

Diabetes & Vascular Disease Research

Free access

Research article

First published 2011-2

Proliferative and Molecular Effects of the Dual PPARα/γ Agonist Tesaglitazar in Rat Adipose Tissues: Relevance for Induction of Fibrosarcoma

Björn Glinghammar, Anna-Lena Berg, Sivert Bjurström [...]

Toxicologic Pathology

Open access

Review article

First published 2022

Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome,Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease—Current Evidence

Emir M. Muzurović, Špela Volčanšek, Karin Zibar Tomšić [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Search results